Frontiers in Pharmacology (Jul 2020)

Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients

  • Giorgio Zauli,
  • Veronica Tisato,
  • Paola Secchiero

DOI
https://doi.org/10.3389/fphar.2020.01156
Journal volume & issue
Vol. 11

Abstract

Read online

No abstracts available.

Keywords